• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

限制平均生存时间作为时间事件结局的总结衡量指标。

Restricted mean survival time as a summary measure of time-to-event outcome.

机构信息

Biostatistics Center, Shionogi & Co, Ltd, Osaka, Japan.

Clinical Development Strategy Department, Pharmaceutical Development Division, Nippon Kayaku Co, Ltd, Tokyo, Japan.

出版信息

Pharm Stat. 2020 Jul;19(4):436-453. doi: 10.1002/pst.2004. Epub 2020 Feb 18.

DOI:10.1002/pst.2004
PMID:32072769
Abstract

Many clinical research studies evaluate a time-to-event outcome, illustrate survival functions, and conventionally report estimated hazard ratios to express the magnitude of the treatment effect when comparing between groups. However, it may not be straightforward to interpret the hazard ratio clinically and statistically when the proportional hazards assumption is invalid. In some recent papers published in clinical journals, the use of restricted mean survival time (RMST) or τ-year mean survival time is discussed as one of the alternative summary measures for the time-to-event outcome. The RMST is defined as the expected value of time to event limited to a specific time point corresponding to the area under the survival curve up to the specific time point. This article summarizes the necessary information to conduct statistical analysis using the RMST, including the definition and statistical properties of the RMST, adjusted analysis methods, sample size calculation, information fraction for the RMST difference, and clinical and statistical meaning and interpretation. Additionally, we discuss how to set the specific time point to define the RMST from two main points of view. We also provide developed SAS codes to determine the sample size required to detect an expected RMST difference with appropriate power and reconstruct individual survival data to estimate an RMST reference value from a reported survival curve.

摘要

许多临床研究评估了事件时间结局,绘制了生存函数,并通常报告了估计的风险比,以表示在组间比较时治疗效果的大小。然而,当比例风险假设不成立时,从临床和统计学角度解释风险比可能并不简单。在最近发表在临床期刊上的一些论文中,讨论了使用受限平均生存时间 (RMST) 或 τ 年平均生存时间作为事件时间结局的替代汇总测量指标之一。RMST 定义为截止到特定时间点的事件时间的期望值,对应于生存曲线下面积截止到特定时间点。本文总结了使用 RMST 进行统计分析所需的必要信息,包括 RMST 的定义和统计特性、调整分析方法、样本量计算、RMST 差异的信息量分数以及临床和统计学意义和解释。此外,我们从两个主要角度讨论了如何设置特定时间点来定义 RMST。我们还提供了开发的 SAS 代码,以确定检测预期 RMST 差异所需的样本量,以获得适当的功效,并重建个体生存数据,以从报告的生存曲线估计 RMST 参考值。

相似文献

1
Restricted mean survival time as a summary measure of time-to-event outcome.限制平均生存时间作为时间事件结局的总结衡量指标。
Pharm Stat. 2020 Jul;19(4):436-453. doi: 10.1002/pst.2004. Epub 2020 Feb 18.
2
[Interpretation and Application of Restricted Mean Survival Time].[受限平均生存时间的解读与应用]
Gan To Kagaku Ryoho. 2022 Apr;49(4):389-396.
3
Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio.使用受限平均生存时间替代风险比来解释癌症临床试验结果的可解释性。
JAMA Oncol. 2017 Dec 1;3(12):1692-1696. doi: 10.1001/jamaoncol.2017.2797.
4
Comparison of the restricted mean survival time with the hazard ratio in superiority trials with a time-to-event end point.在具有事件发生时间终点的优效性试验中,受限平均生存时间与风险比的比较。
Pharm Stat. 2018 May;17(3):202-213. doi: 10.1002/pst.1846. Epub 2017 Dec 28.
5
[Application of restricted mean survival time in clinical follow-up study].受限平均生存时间在临床随访研究中的应用
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Feb 10;40(2):247-250. doi: 10.3760/cma.j.issn.0254-6450.2019.02.023.
6
Dynamic RMST curves for survival analysis in clinical trials.用于临床试验生存分析的动态受限平均生存时间曲线
BMC Med Res Methodol. 2020 Aug 27;20(1):218. doi: 10.1186/s12874-020-01098-5.
7
A comparison of different population-level summary measures for randomised trials with time-to-event outcomes, with a focus on non-inferiority trials.不同人群水平汇总指标在时间事件结局随机试验中的比较,重点关注非劣效性试验。
Clin Trials. 2023 Dec;20(6):594-602. doi: 10.1177/17407745231181907. Epub 2023 Jun 20.
8
Treatment effects measured by restricted mean survival time in trials of immune checkpoint inhibitors for cancer.免疫检查点抑制剂治疗癌症的临床试验中通过受限平均生存时间衡量的治疗效果。
Ann Oncol. 2018 May 1;29(5):1320-1324. doi: 10.1093/annonc/mdy075.
9
Utility of Restricted Mean Survival Time Analysis for Heart Failure Clinical Trial Evaluation and Interpretation.限制平均生存时间分析在心力衰竭临床试验评估和解释中的应用。
JACC Heart Fail. 2020 Dec;8(12):973-983. doi: 10.1016/j.jchf.2020.07.005. Epub 2020 Oct 7.
10
Sensitivity Analysis for Restricted Mean Survival Time When Survival Curves Have Divergent Tails.生存曲线具有发散尾部时受限平均生存时间的敏感性分析
Ther Innov Regul Sci. 2023 May;57(3):467-471. doi: 10.1007/s43441-022-00484-z. Epub 2023 Jan 3.

引用本文的文献

1
Characterizing the impact of a novel electronic consultation platform on access to Hepatitis C treatment in a Manitoba context.在曼尼托巴省的背景下,评估一个新型电子咨询平台对丙型肝炎治疗可及性的影响。
Healthc Manage Forum. 2025 Jun 23;38(5):8404704251350064. doi: 10.1177/08404704251350064.
2
Prognostic Features for Overall Survival in Male Diabetic Patients Undergoing Hemodialysis Using Elastic Net Penalized Cox Regression; A Machine Learning Approach.使用弹性网络惩罚Cox回归对接受血液透析的男性糖尿病患者总生存的预后特征;一种机器学习方法。
Arch Iran Med. 2025 Jan 1;28(1):9-17. doi: 10.34172/aim.27746.
3
Modeling the Restricted Mean Survival Time Using Pseudo-Value Random Forests.
使用伪值随机森林对受限平均生存时间进行建模。
Stat Med. 2025 Feb 28;44(5):e70031. doi: 10.1002/sim.70031.
4
A Comparison of Statistical Methods for Time-To-Event Analyses in Randomized Controlled Trials Under Non-Proportional Hazards.非比例风险下随机对照试验中事件发生时间分析的统计方法比较
Stat Med. 2025 Feb 28;44(5):e70019. doi: 10.1002/sim.70019.
5
Comparison between asymptotic and re-randomisation tests under non-proportional hazards in a randomised controlled trial using the minimisation method.最小化法在非比例风险随机对照试验中渐近检验和再随机检验的比较。
BMC Med Res Methodol. 2024 Jul 30;24(1):166. doi: 10.1186/s12874-024-02295-2.
6
Regression models for average hazard.平均风险的回归模型。
Biometrics. 2024 Mar 27;80(2). doi: 10.1093/biomtc/ujae037.
7
Simultaneous inference procedures for the comparison of multiple characteristics of two survival functions.同时比较两种生存函数多个特征的推断程序。
Stat Methods Med Res. 2024 Apr;33(4):589-610. doi: 10.1177/09622802241231497. Epub 2024 Mar 11.
8
Statistical considerations in long-term efficacy evaluation of anti-cancer therapies.抗癌疗法长期疗效评估中的统计学考量
Front Pharmacol. 2023 Oct 3;14:1265953. doi: 10.3389/fphar.2023.1265953. eCollection 2023.
9
Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) Study.常见镇痛药与卵巢癌生存:卵巢癌预后与生活方式(OPAL)研究。
J Natl Cancer Inst. 2023 May 8;115(5):570-577. doi: 10.1093/jnci/djac239.
10
Fast pain relief in exercise-induced acute musculoskeletal pain by turmeric-boswellia formulation: A randomized placebo-controlled double-blinded multicentre study.姜黄-乳香配方对运动诱发的急性肌肉骨骼疼痛的快速止痛作用:一项随机安慰剂对照双盲多中心研究。
Medicine (Baltimore). 2022 Sep 2;101(35):e30144. doi: 10.1097/MD.0000000000030144.